Mandate

Vinge advises Varyag Resources

May 11, 2009

Vinge has advised Varyag Resources AB (publ) listed on First North in connection with a restructuring of Varyag Resources which entails a change of strategy and structure from a private equity to a forestry company.

The reconstruction entails an acquisition of 50 per cent of the shares in RusForest Ltd and of receivables against RusForest amounting to approximately MRUB 800 from a wholly-owned subsidiary of Vostok Nafta Investment Ltd. Payment will be made in the form of newly-issued shares in Varyag Resources to an estimated value at the time of contracting of approximately SEK 156 million.

Vinge’s team primarily consisted of partners Göran Nyström and Malin Leffler together with, among others, associates Jonas Johansson and Andreas Wirén.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026